Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Fleckenstein

Showing results (71-80 of 131) with videos related to

Pageof 14
Sort By:
Annals of the New York Academy of Sciences|July 21, 1998
Methamphetamine-induced rapid and reversible reduction in the activities of tryptophan hydroxylase and dopamine transporters: oxidative consequences?G R Hanson, J W Gibb, R R Metzger, et al.
European Journal of Pharmacology|September 12, 1996
Highly potent cocaine analogs cause long-lasting increases in locomotor activityA E Fleckenstein, T A Kopajtic, J W Boja, et al.
European Journal of Pharmacology|November 5, 1997
Oxygen radicals diminish dopamine transporter function in rat striatumA E Fleckenstein, R R Metzger, M L Beyeler, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1997
Rapid and reversible effects of methamphetamine on dopamine transportersA E Fleckenstein, R R Metzger, D G Wilkins, et al.
Brain Research|April 25, 2000
Differential effects of methamphetamine on Na(+)/Cl(-)-dependent transportersH M Haughey, J M Brown, D G Wilkins, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 2, 2004
Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanismAnthony J Baucum, Kristi S Rau, Evan L Riddle, et al.
Pharmacological Reviews|September 27, 2015
Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for DiseaseChristopher L German, Michelle G Baladi, Lisa M McFadden, et al.
Synapse (New York, N.Y.)|November 21, 2008
Age-dependent differences in dopamine transporter and vesicular monoamine transporter-2 function and their implications for methamphetamine neurotoxicityTrent J Volz, Sarah J Farnsworth, Shane D Rowley, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 13, 2010
Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activationGregory C Hadlock, Pei-Wen Chu, Elliot T Walters, et al.
Synapse (New York, N.Y.)|August 27, 2014
Mephedrone alters basal ganglia and limbic dynorphin systemsChristopher L German, Mario E Alburges, Amanda J Hoonakker, et al.
Pageof 14

Showing results (71-80 of 131) with videos related to

Sort By:
Pageof 14
Annals of the New York Academy of Sciences|July 21, 1998
Methamphetamine-induced rapid and reversible reduction in the activities of tryptophan hydroxylase and dopamine transporters: oxidative consequences?G R Hanson, J W Gibb, R R Metzger, et al.
European Journal of Pharmacology|September 12, 1996
Highly potent cocaine analogs cause long-lasting increases in locomotor activityA E Fleckenstein, T A Kopajtic, J W Boja, et al.
European Journal of Pharmacology|November 5, 1997
Oxygen radicals diminish dopamine transporter function in rat striatumA E Fleckenstein, R R Metzger, M L Beyeler, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1997
Rapid and reversible effects of methamphetamine on dopamine transportersA E Fleckenstein, R R Metzger, D G Wilkins, et al.
Brain Research|April 25, 2000
Differential effects of methamphetamine on Na(+)/Cl(-)-dependent transportersH M Haughey, J M Brown, D G Wilkins, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 2, 2004
Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanismAnthony J Baucum, Kristi S Rau, Evan L Riddle, et al.
Pharmacological Reviews|September 27, 2015
Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for DiseaseChristopher L German, Michelle G Baladi, Lisa M McFadden, et al.
Synapse (New York, N.Y.)|November 21, 2008
Age-dependent differences in dopamine transporter and vesicular monoamine transporter-2 function and their implications for methamphetamine neurotoxicityTrent J Volz, Sarah J Farnsworth, Shane D Rowley, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 13, 2010
Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activationGregory C Hadlock, Pei-Wen Chu, Elliot T Walters, et al.
Synapse (New York, N.Y.)|August 27, 2014
Mephedrone alters basal ganglia and limbic dynorphin systemsChristopher L German, Mario E Alburges, Amanda J Hoonakker, et al.
Pageof 14